Fjarde AP Fonden Fourth Swedish National Pension Fund Acquires 1,291 Shares of Becton, Dickinson and Company (BDX)

Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in Becton, Dickinson and Company (NYSE:BDX) by 2.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 54,059 shares of the medical instruments supplier’s stock after acquiring an additional 1,291 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Becton, Dickinson and were worth $10,593,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in BDX. BlackRock Inc. increased its holdings in shares of Becton, Dickinson and by 2,427.8% in the 1st quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock valued at $3,034,470,000 after purchasing an additional 15,887,611 shares in the last quarter. Koch Industries Inc. increased its holdings in shares of Becton, Dickinson and by 45,268.7% in the 2nd quarter. Koch Industries Inc. now owns 1,398,264 shares of the medical instruments supplier’s stock valued at $1,391,000 after purchasing an additional 1,395,182 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Becton, Dickinson and by 8.5% in the 2nd quarter. Vanguard Group Inc. now owns 17,255,948 shares of the medical instruments supplier’s stock valued at $3,366,809,000 after purchasing an additional 1,353,780 shares in the last quarter. Winslow Capital Management LLC purchased a new position in shares of Becton, Dickinson and in the 2nd quarter valued at about $225,164,000. Finally, Janus Henderson Group PLC increased its holdings in shares of Becton, Dickinson and by 1,265.9% in the 2nd quarter. Janus Henderson Group PLC now owns 1,210,837 shares of the medical instruments supplier’s stock valued at $236,245,000 after purchasing an additional 1,122,191 shares in the last quarter. Institutional investors own 86.01% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Fjarde AP Fonden Fourth Swedish National Pension Fund Acquires 1,291 Shares of Becton, Dickinson and Company (BDX)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/11/17/fjarde-ap-fonden-fourth-swedish-national-pension-fund-acquires-1291-shares-of-becton-dickinson-and-company-bdx.html.

Shares of Becton, Dickinson and Company (NYSE BDX) traded up $2.42 during mid-day trading on Friday, reaching $221.52. 897,700 shares of the company’s stock were exchanged, compared to its average volume of 1,328,003. The firm has a market capitalization of $49,859.49, a PE ratio of 23.09, a price-to-earnings-growth ratio of 1.72 and a beta of 1.04. The company has a current ratio of 5.56, a quick ratio of 5.01 and a debt-to-equity ratio of 1.48. Becton, Dickinson and Company has a 1 year low of $161.29 and a 1 year high of $225.23.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $2.37 by $0.03. The firm had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.14 billion. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 22.51%. Becton, Dickinson and’s revenue was down 2.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.12 earnings per share. research analysts anticipate that Becton, Dickinson and Company will post 10.63 earnings per share for the current fiscal year.

A number of equities analysts have recently issued reports on BDX shares. Bank of America Corporation reiterated a “buy” rating and issued a $225.00 price target (up previously from $200.00) on shares of Becton, Dickinson and in a report on Friday, July 21st. BidaskClub downgraded shares of Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research downgraded shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Monday, August 7th. Stifel Nicolaus restated a “buy” rating on shares of Becton, Dickinson and in a report on Wednesday, August 9th. Finally, Barclays PLC restated an “equal weight” rating and set a $210.00 target price (up from $205.00) on shares of Becton, Dickinson and in a report on Thursday, August 10th. Five investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. Becton, Dickinson and has an average rating of “Buy” and an average target price of $213.47.

In other news, insider Stephen Sichak sold 11,787 shares of Becton, Dickinson and stock in a transaction that occurred on Friday, September 8th. The shares were sold at an average price of $200.46, for a total transaction of $2,362,822.02. Following the sale, the insider now owns 14,038 shares in the company, valued at $2,814,057.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Linda M. Tharby sold 4,695 shares of Becton, Dickinson and stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $200.48, for a total transaction of $941,253.60. Following the sale, the executive vice president now owns 18,670 shares in the company, valued at approximately $3,742,961.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 47,038 shares of company stock worth $9,480,225. 1.40% of the stock is currently owned by corporate insiders.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply